Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cannabinoid
Therapeutic Area : Neurology
Study Phase : Undisclosed
Recipient : FSD Pharma
Deal Size : Undisclosed
Deal Type : Agreement
FSD Pharma and Solarvest Enhance Commitment to CBD Research Project
Details : Under the amended Research Agreement, FSD Pharma has agreed to issue additional class B subordinate voting shares to Solarvest, which will enable Solarvest to fund the CBD Research Project.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Undisclosed
February 04, 2020
Lead Product(s) : Cannabinoid
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Recipient : FSD Pharma
Deal Size : Undisclosed
Deal Type : Agreement
Reset All
